参考资料: [1]https://www.dailymail.co.uk/health/article-11624959/FDA-CDC-vaccine-advisers-angry-early-data-Covid-19-booster-shot-withheld-year.html [2]Chalkias S, Eder F, Essink B,et al. Safety, immunogenicity and antibody persistence of a bivalent Beta-containing booster vaccine against ...
Dec 8, 2022Moderna Receives FDA Emergency Use Authorization for Omicron-Targeting Bivalent COVID-19 Booster Vaccine in Children 6 Months Through 5 Years of Age Nov 14, 2022Moderna's BA.4/BA.5 Targeting Bivalent Booster, mRNA-1273.222, Meets Primary Endpoint of Superiority Against Omicron Variants...
Moderna, Inc. announced that the European Medicines Agency has accepted a variation for the evaluation of a 50 µg booster dose of the Omicron-containing bivalent COVID booster candidate, mRNA-1273.222 in adults 12 year...